Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives
International Journal of Molecular Sciences · 07.09.2023 · 24 (18) · 13827
DOI: 10.3390/ijms241813827 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.09.2023. Verfasst von Sergio Almansa-Gómez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yeast Physiology Group, Departamento de Genética y Microbiología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain. Hauptthemen laut MEDLINE: Osteosarcoma, Drug-Related Side Effects and Adverse Reactions, Bone Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Séneca - Agencia de Ciencia y Tecnología de la Región de Murcia, Agencia Estatal de Investigación, Fundación Séneca de la Región de Murcia.
Abstract (Originalsprache)
Autophagy, the process that enables the recycling and degradation of cellular components, is essential for homeostasis, which occurs in response to various types of stress. Autophagy plays an important role in the genesis and evolution of osteosarcoma (OS). The conventional treatment of OS has limitations and is not always effective at controlling the disease. Therefore, numerous researchers have analyzed how controlling autophagy could be used as a treatment or strategy to reverse resistance to therapy in OS. They highlight how the inhibition of autophagy improves the efficacy of chemotherapeutic treatments and how the promotion of autophagy could prove positive in OS therapy. The modulation of autophagy can also be directed against OS stem cells, improving treatment efficacy and preventing cancer recurrence. Despite promising findings, future studies are needed to elucidate the molecular mechanisms of autophagy and its relationship to OS, as well as the mechanisms underlying the functioning of autophagic modulators. Careful evaluation is required as autophagy modulation may have adverse effects on normal cells, and the optimization of autophagic modulators for use as drugs in OS is imperative.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yeast Physiology Group, Departamento de Genética y Microbiología, Facultad de Biología, Universidad de Murcia, 30100 Murcia, Spain.
ORCID-Profile: Francisco Prieto-Ruiz, Marisa Madrid
Förderung
- Fundación Séneca - Agencia de Ciencia y Tecnología de la Región de Murcia
- Agencia Estatal de Investigación
- Fundación Séneca de la Región de Murcia
- European Regional Development Fund (ERDF)
Zitieren
APA
Almansa-Gómez, S., Prieto-Ruiz, F., Cansado, J., & Madrid, M. (2023). Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives. International Journal of Molecular Sciences, 24(18), 13827. https://doi.org/10.3390/ijms241813827
Vancouver
Almansa-Gómez S, Prieto-Ruiz F, Cansado J, Madrid M. Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives. International Journal of Molecular Sciences. 2023;24(18):13827. doi:10.3390/ijms241813827
BibTeX
@article{AlmansaGmez2023,
author = {Almansa-Gómez, Sergio and Prieto-Ruiz, Francisco and Cansado, José and Madrid, Marisa},
title = {Autophagy Modulation as a Potential Therapeutic Strategy in Osteosarcoma: Current Insights and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {18},
pages = {13827},
doi = {10.3390/ijms241813827}
}
EUVIMED